Why the study?
Previous studies confirmed the link between metabolic syndrome and CAD risk, but its influence on the severity of angiographic lesions in myocardial infarction required further investigation.
Does metabolic syndrome increase the severity of angiographic coronary artery lesions in patients with myocardial infarction?
Does metabolic syndrome increase the severity of angiographic coronary artery lesions in patients with myocardial infarction?
Metabolic syndrome is associated with significantly more severe, multi-vessel coronary artery disease in patients presenting with myocardial infarction.
Metabolic syndrome may flag higher-risk MI anatomy; leaves open whether screening or therapy alters prognosis.
Introduction: Previous epidemiological and clinical studies confirmed the relation between metabolic syndrome and an increased risk of coronary artery disease (CAD). There was a significant correlation between the syndrome and more severe angiographic lesions in the coronary arteries of these patients. Objective: We aimed at investigating the importance and influence of the metabolic syndrome on the severity of the angiographic lesions in the coronary arteries of the patients with myocardial infarction. Method: The research included 143 participants with a myocardial infarction, of whom 81 (58.7±6.2) had metabolic syndrome and 62 (54.9±10.3) were without it (p<0.01). Physical examinations, anthropometric measurements, lab results, and coronarography were performed in all patients. To diagnose the metabolic syndrome (MS) we used the American Heart Association`s and National Heart Lung and Blood Institute`s criteria. Results: Participants with MS, when compared to those without MS, had: single-vessel CAD 8,6% vs 46,8% (p<0,001), double-vessel CAD 25,9% vs 32,3% (p>0,05), triple-vessel CAD 65,4% vs 21,0% (p<0,001), multi-vessel CAD 91,3% vs 53,2% (p<0,001). When we compared the affected coronary arteries of the patients with MS and those without MS we found: LAD 88,9% vs 71,0% (p<0,01), LCx 64,2% vs 29,0% (p<0,01), RCA 80,2% vs 61,3% (p<0,01), LM 14,8% vs 1,6%. Conclusion: Patients with MS had more severe coronary artery lesions, with a higher incidence of triple-vessel and multi-vessel disease, as well as stenosis of LAD, LCX. RCA, LM, when compared to those without MS. This clearly indicates MS is a significant risk factor for more severe CAD.
No takes yet. Share an insight, caveat, or question.
Dušan Miljković (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: